Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococci and Hib Vaccination Early and Late After Neurotrauma or Neurosurgery
NCT02806284Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Jan 2001
- Primary completion
- Jan 2008
- Modality
- Split/Subunit Vaccines
01
Overview
A Phase 2 trial of 23-valent pneumococcal polysaccharide vaccine, Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen in meningitis, sponsored by Uppsala University. Started Jan 2001; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccineHaemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
03
Conditions
meningitis
Beyond the preview
Go deeper on NCT02806284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806284.